Navigation Links
Reportlinker Adds Biomarkers - technologies, markets and companies
Date:9/7/2010

NEW YORK, Sept. 7 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Biomarkers - technologies,markets and companies

http://www.reportlinker.com/p0203536/Biomarkers---technologiesmarkets-and-companies.html

Summary

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological responses to a therapeutic intervention. Tests based on biomarkers have been around for more than half a century, but interest in their application for diagnostics and drug discovery as well as development has increased remarkably since the beginning of the 21st century. This report describes different types of biomarkers and their discovery using various "-omics" technologies such as proteomics and metabolomics. Molecular diagnostics technologies are used for the discovery of biomarkers and new tests are also based on biomarker.

Currently the most important applications of biomarkers are in drug discovery and development. The role of biomarkers in various therapeutic areas particularly cancer, cardiovascular diseases and disorders of the central nervous system, is described. Biomarkers are useful not only for diagnosis of some of these diseases but also for understanding the pathomechanism as well as a basis for development of therapeutics.

Biomarkers will facilitate the combination of therapeutics with diagnostics and will thus play an important role in the development of personalized medicine. Biomarkers play a role in use of pharmacogenetics, pharmacogenomics and pharma
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology news :

1. Reportlinker Adds Carbon Dioxide Monitors Report
2. Reportlinker Adds World Dynamic Signature Verification Market Report
3. Reportlinker Adds Proteomics: Technologies and Global Markets Report
4. Biomarkers for identifying infant infections
5. Compendium of pancreatic cancer biomarkers established as strategic approach to early-detection
6. Prostate Cancer Translational Research in Europe meeting: Search for biomarkers continues
7. Assessing lead time of selected ovarian cancer biomarkers
8. Pacific Biometrics, Inc. Stockholders Approve Company Name Change to Pacific Biomarkers, Inc.
9. Scientists use nanosensors for first time to measure cancer biomarkers in blood
10. Pacific Biomarkers, Inc. Schedules Second Quarter Conference Call for Friday, February 12, 2010
11. New biomarkers for predicting the spread of colon cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Jan. 16, 2015  A man-made form of insulin delivered ... mental capabilities in adults with mild cognitive impairment and ... by researchers at Wake Forest Baptist Medical Center. ... amnesic mild cognitive impairment (MCI) or mild to moderate ...
(Date:1/22/2015)... DUBLIN , Jan. 22, 2015 Research and ... the addition of the "Global Wearable Technologies ... Growth, Share, Overview, Trends and Forecast 2014-2020" ... Wearable Technologies are smart devices that can be ...
(Date:12/22/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/fx4bg3/the_global ... "The Global Watermarking and Fingerprinting Markets" report ... http://photos.prnewswire.com/prnh/20130307/600769 This insight provides an ... fingerprinting markets. Watermarking aims to control and monitor ...
Breaking Biology News(10 mins):Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2The Global Watermarking and Fingerprinting Markets 2
... revealed what may well be the first pervasive rule ... the Proceedings of the National Academy of Sciences researchers ... to become increasingly more complex. Looking back ... catalogue to the present day, the team investigated the ...
... not only smart, but they also wage a good ... studies have shown that plants can sense attacks by ... been known what happens between the pathogen attacks and ... revealed a very complex process that explains how plants ...
... holds three patents in the emerging field of nanotechnology ... the technology,s potential in materials science and medicine. ... a strong call for exploring potential environmental and health ... designing new materials with reduced hazard. The available data, ...
Cached Biology News:First 'rule' of evolution suggests that life is destined to become more complex 2Researcher discovers pathway plants use to fight back against pathogens 2Think green, UO's Hutchison says, to reduce nanotech hazards 2Think green, UO's Hutchison says, to reduce nanotech hazards 3
(Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
(Date:12/24/2014)... , Dec. 24, 2014   BioLife Solutions , Inc. ... marketer of proprietary clinical grade hypothermic storage and ... products for cells and tissues  ("BioLife" or the "Company"), ... of Stockholders on May 4, 2015 (the "Annual Meeting"). ...
(Date:12/24/2014)... December 23, 2014 Earlier this year in ... director of the Adult Stem Cell Technology Center, LLC ( ... appreciated unique property of adult tissue stem cells. His ... Past, Important for the Future,” embodied the essence of his ...
(Date:12/24/2014)... 2014 According to Ross Selinger, President of ... ITRA Global, the national office market continues to be strong, ... is evidenced by the third quarter’s surprising 3.9% GDP, unemployment ... energy costs have held inflation down and the Fed is ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3
... JERUSALEM, Israel , May 6, 2010 ... delivery,systems, reported today results for the recently completed Phase 2b non-FDA,clinical ... , , ... randomized, double-blind, placebo-controlled, multi-centered study,conducted in South Africa evaluated ...
... 6 Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ... webcast discussing the Company,s 2010 first quarter financial results on ... Michael T. Flavin , Ph.D., Chairman & Chief Executive Officer, ... present an update on the Company. A press release reporting the ...
... consist of three main parts: endosperm, bran and germ. In ... based on kernels or flour after removal of bran and ... and other bioactive components. In the past decade consumers have ... of whole grain products is growing world wide and in ...
Cached Biology Technology:Oramed Pharmaceuticals Reports Results in Phase 2b Trial of Oral Insulin Administration to Type 2 Diabetes Patients 2Oramed Pharmaceuticals Reports Results in Phase 2b Trial of Oral Insulin Administration to Type 2 Diabetes Patients 3Advanced Life Sciences to Host 2010 First Quarter Financial Results Conference Call and Webcast 2The European HEALTHGRAIN consortium developed a definition for whole grain 2